Pharming PHAR
NASDAQ PHAR
$9.99 -0.02 (-0.20%)
At close: Sep 30, 2026 · 4:00 PM EDT

Pharming (PHAR) Other Non-Current Liabilities (2019 - 2025)

Updated

Pharming (PHAR) recorded Other Non-Current Liabilities of -$2.56 million in Q4 2025, compared with -$3.4 million a year earlier.

Analysis

Pharming (PHAR) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends

Starting with Q4 2019, Pharming's Other Non-Current Liabilities history includes 9 quarters.

  • Across earlier years, Other Non-Current Liabilities came in at -$3.4 million in FY2024, -$3.24 million in FY2023 and -$25 million in FY2021.
  • The Q4 2025 figure is the highest quarterly Other Non-Current Liabilities since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Pharming 702.38 Mn -127.78 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.56 Mn
Dec 31, 2024 -3.40 Mn
Dec 31, 2023 -3.24 Mn
Sep 30, 2021 54,000.00
Jun 30, 2021 -25.00 Mn
Mar 31, 2021 84,000.00
Dec 31, 2020 175,266.61
Sep 30, 2020 -20.45 Mn
Dec 31, 2019 296,645.90
API Access

Pharming Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PHAR&period=max&api_key=YOUR_API_KEY